
Merck Kicks Off 2023 Curiosity Cube Mobile Lab Tour
Merck has kicked off its 2023 Curiosity Cube tour in Europe and North America. Merck, a leading science and technology company, has kicked off its […]
Merck has kicked off its 2023 Curiosity Cube tour in Europe and North America. Merck, a leading science and technology company, has kicked off its […]
Merck is breaking ground today in Kaohsiung, Taiwan, for a new production facility in its Semiconductor Solutions business. • Good progress being made with the […]
Merck announced the closing of the transaction to acquire M Chemicals Inc., the company recently incorporated by Mecaro Co. Ltd. to operate its chemical business. […]
• Responds to growing global demand for biosafety testing as essential requirement for drug development and commercialization • Expansion creates more than 500 new jobs […]
Merck presents two new cosmetic active ingredients for the Asian Pacific market at this year’s in-cosmetics™ Asia that takes place in Bangkok from Nov 1-3: […]
….to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain. • Proof of Concept (PoC) successfully provides primary packaging with a […]
Merck will present 39 abstracts at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). • Company’s scientific leadership […]
…First BTKi to Demonstrate Sustained Clinical Benefit for People with RMS through Three and a Half Years of Treatment This data suggests the long-term positive […]
Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform Merck has launched […]
…to Fill Industry Gap in Process Analytical Technologies for Downstream Processing Merck today announced that it has entered a collaboration with Agilent Technologies to advance […]
The acquisition of the MAST® platform is another milestone to accelerate innovation in Merck’s Process Solutions business unit. Merck to become first company to offer […]
….of the Life Science business sector. • New operating model to accelerate profitable growth strategy • Newly formed Life Science Services business unit to offer […]
Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD 780 million in cash. Targeted […]
Merck today announced the expansion of its strategic, corporate venture capital arm M Ventures. Merck, a leading science and technology company, today announced the expansion […]
Merck plans to invest € 270 million at its global headquarters in Darmstadt by building a new Translational Science Center for its Healthcare business sector […]
Copyright © 2023 | WordPress Theme by MH Themes